BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu X, Chen X, Zhou Q, Li P, Yu B, Li J, Qu Y, Yan J, Yu Y, Yan M, Zhu Z, Liu B, Su L. Hepatocyte growth factor activates tumor stromal fibroblasts to promote tumorigenesis in gastric cancer. Cancer Lett 2013;335:128-35. [PMID: 23402812 DOI: 10.1016/j.canlet.2013.02.002] [Cited by in Crossref: 50] [Cited by in F6Publishing: 52] [Article Influence: 5.6] [Reference Citation Analysis]
Number Citing Articles
1 Meng Q, Luo X, Chen J, Wang D, Chen E, Zhang W, Zhang G, Zhou W, Xu J, Song Z. Unmasking carcinoma-associated fibroblasts: Key transformation player within the tumor microenvironment. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2020;1874:188443. [DOI: 10.1016/j.bbcan.2020.188443] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
2 Hao NB, Tang B, Wang GZ, Xie R, Hu CJ, Wang SM, Wu YY, Liu E, Xie X, Yang SM. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis. Cancer Lett. 2015;361:57-66. [PMID: 25727320 DOI: 10.1016/j.canlet.2015.02.043] [Cited by in Crossref: 48] [Cited by in F6Publishing: 55] [Article Influence: 6.9] [Reference Citation Analysis]
3 Chen R, Huang L, Hu K. Natural products remodel cancer-associated fibroblasts in desmoplastic tumors. Acta Pharm Sin B 2020;10:2140-55. [PMID: 33304782 DOI: 10.1016/j.apsb.2020.04.005] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
4 Zhou B, Chen WL, Wang YY, Lin ZY, Zhang DM, Fan S, Li JS. A role for cancer-associated fibroblasts in inducing the epithelial-to-mesenchymal transition in human tongue squamous cell carcinoma. J Oral Pathol Med 2014;43:585-92. [PMID: 24645915 DOI: 10.1111/jop.12172] [Cited by in Crossref: 44] [Cited by in F6Publishing: 45] [Article Influence: 5.5] [Reference Citation Analysis]
5 Jin Z, Lu Y, Wu X, Pan T, Yu Z, Hou J, Wu A, Li J, Yang Z, Li C, Yan M, Yan C, Zhu Z, Liu B, Qiu W, Su L. The cross-talk between tumor cells and activated fibroblasts mediated by lactate/BDNF/TrkB signaling promotes acquired resistance to anlotinib in human gastric cancer. Redox Biol 2021;46:102076. [PMID: 34315112 DOI: 10.1016/j.redox.2021.102076] [Reference Citation Analysis]
6 Li X, Fang T, Xu S, Jin P, Zhou D, Wang Z, Li H, Yang Z, Chen G, Zheng X, Xia Y, Wei X, Zhang Z, Yang X, Wang Y, Gao Q. PARP inhibitors promote stromal fibroblast activation by enhancing CCL5 autocrine signaling in ovarian cancer. NPJ Precis Oncol 2021;5:49. [PMID: 34108603 DOI: 10.1038/s41698-021-00189-w] [Reference Citation Analysis]
7 Yu T, Gong L, Li W, Zuo Q, Cai D, Mao H, Wang L, Lin J, Xiao B. MiR-30a suppresses metastasis of gastric adenocarcinoma via targeting FAPα. Cancer Biomark 2020;27:471-84. [PMID: 32116236 DOI: 10.3233/CBM-190314] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Ichikawa T, Aokage K, Sugano M, Miyoshi T, Kojima M, Fujii S, Kuwata T, Ochiai A, Suzuki K, Tsuboi M, Ishii G. The ratio of cancer cells to stroma within the invasive area is a histologic prognostic parameter of lung adenocarcinoma. Lung Cancer 2018;118:30-5. [PMID: 29571999 DOI: 10.1016/j.lungcan.2018.01.023] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
9 Singh S, Tran S, Putman J, Tavana H. Three-dimensional models of breast cancer-fibroblasts interactions. Exp Biol Med (Maywood) 2020;245:879-88. [PMID: 32276543 DOI: 10.1177/1535370220917366] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Chen YS, Huang TH, Liu CL, Chen HS, Lee MH, Chen HW, Shen CR. Locally Targeting the IL-17/IL-17RA Axis Reduced Tumor Growth in a Murine B16F10 Melanoma Model. Hum Gene Ther 2019;30:273-85. [PMID: 30079767 DOI: 10.1089/hum.2018.104] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
11 Bradley CA, Salto-Tellez M, Laurent-Puig P, Bardelli A, Rolfo C, Tabernero J, Khawaja HA, Lawler M, Johnston PG, Van Schaeybroeck S; MErCuRIC consortium. Targeting c-MET in gastrointestinal tumours: rationale, opportunities and challenges. Nat Rev Clin Oncol. 2017;14:562-576. [PMID: 28374784 DOI: 10.1038/nrclinonc.2017.40] [Cited by in Crossref: 79] [Cited by in F6Publishing: 78] [Article Influence: 15.8] [Reference Citation Analysis]
12 Makowiecka A, Simiczyjew A, Nowak D, Mazur AJ. Varying effects of EGF, HGF and TGFβ on formation of invadopodia and invasiveness of melanoma cell lines of different origin. Eur J Histochem 2016;60:2728. [PMID: 28076931 DOI: 10.4081/ejh.2016.2728] [Cited by in Crossref: 11] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
13 Ishii G, Ochiai A, Neri S. Phenotypic and functional heterogeneity of cancer-associated fibroblast within the tumor microenvironment. Advanced Drug Delivery Reviews 2016;99:186-96. [DOI: 10.1016/j.addr.2015.07.007] [Cited by in Crossref: 195] [Cited by in F6Publishing: 194] [Article Influence: 32.5] [Reference Citation Analysis]
14 Spina A, De Pasquale V, Cerulo G, Cocchiaro P, Della Morte R, Avallone L, Pavone LM. HGF/c-MET Axis in Tumor Microenvironment and Metastasis Formation. Biomedicines 2015;3:71-88. [PMID: 28536400 DOI: 10.3390/biomedicines3010071] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 3.6] [Reference Citation Analysis]
15 Gebauer N, Schmidt-Werthern C, Bernard V, Feller AC, Keck T, Begum N, Rades D, Lehnert H, Brabant G, Thorns C. Genomic landscape of pancreatic neuroendocrine tumors. World J Gastroenterol 2014; 20(46): 17498-17506 [PMID: 25516664 DOI: 10.3748/wjg.v20.i46.17498] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
16 Kuzet SE, Gaggioli C. Fibroblast activation in cancer: when seed fertilizes soil. Cell Tissue Res 2016;365:607-19. [PMID: 27474009 DOI: 10.1007/s00441-016-2467-x] [Cited by in Crossref: 99] [Cited by in F6Publishing: 99] [Article Influence: 16.5] [Reference Citation Analysis]
17 Rihawi K, Ricci AD, Rizzo A, Brocchi S, Marasco G, Pastore LV, Llimpe FLR, Golfieri R, Renzulli M. Tumor-Associated Macrophages and Inflammatory Microenvironment in Gastric Cancer: Novel Translational Implications. Int J Mol Sci 2021;22:3805. [PMID: 33916915 DOI: 10.3390/ijms22083805] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Suzuki J, Tsuboi M, Ishii G. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer. Expert Rev Anticancer Ther 2022;:1-14. [PMID: 34904919 DOI: 10.1080/14737140.2022.2019018] [Reference Citation Analysis]
19 An YZ, Cho E, Ling J, Zhang X. The Axin2-snail axis promotes bone invasion by activating cancer-associated fibroblasts in oral squamous cell carcinoma. BMC Cancer 2020;20:987. [PMID: 33046030 DOI: 10.1186/s12885-020-07495-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
20 Zhang M, Gao S, Yang D, Fang Y, Lin X, Jin X, Liu Y, Liu X, Su K, Shi K. Influencing factors and strategies of enhancing nanoparticles into tumors in vivo. Acta Pharm Sin B 2021;11:2265-85. [PMID: 34522587 DOI: 10.1016/j.apsb.2021.03.033] [Cited by in Crossref: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Wang C, Xi W, Ji J, Cai Q, Zhao Q, Jiang J, Zhou C, Shi M, Zhang H, Zhu Z, Zhang J. The prognostic value of HGF-c-MET signaling pathway in Gastric Cancer: a study based on TCGA and GEO databases. Int J Med Sci 2020;17:1946-55. [PMID: 32788873 DOI: 10.7150/ijms.44952] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
22 Chang H, Liu XQ, Hu M, Zhang H, Li BC, Ren KF, Boudou T, Albiges-Rizo C, Picart C, Ji J. Substrate Stiffness Combined with Hepatocyte Growth Factor Modulates Endothelial Cell Behavior. Biomacromolecules 2016;17:2767-76. [PMID: 27428305 DOI: 10.1021/acs.biomac.6b00318] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 4.2] [Reference Citation Analysis]
23 Wang X, Che X, Liu C, Fan Y, Bai M, Hou K, Shi X, Zhang X, Liu B, Zheng C, Liu Y, Qu X. Cancer-associated fibroblasts-stimulated interleukin-11 promotes metastasis of gastric cancer cells mediated by upregulation of MUC1. Experimental Cell Research 2018;368:184-93. [DOI: 10.1016/j.yexcr.2018.04.028] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
24 Heneberg P. Paracrine tumor signaling induces transdifferentiation of surrounding fibroblasts. Crit Rev Oncol Hematol. 2016;97:303-311. [PMID: 26467073 DOI: 10.1016/j.critrevonc.2015.09.008] [Cited by in Crossref: 48] [Cited by in F6Publishing: 46] [Article Influence: 6.9] [Reference Citation Analysis]
25 Li P, Shan JX, Chen XH, Zhang D, Su LP, Huang XY, Yu BQ, Zhi QM, Li CL, Wang YQ. Epigenetic silencing of microRNA-149 in cancer-associated fibroblasts mediates prostaglandin E2/interleukin-6 signaling in the tumor microenvironment. Cell Res. 2015;25:588-603. [PMID: 25916550 DOI: 10.1038/cr.2015.51] [Cited by in Crossref: 89] [Cited by in F6Publishing: 85] [Article Influence: 12.7] [Reference Citation Analysis]
26 Baj J, Brzozowska K, Forma A, Maani A, Sitarz E, Portincasa P. Immunological Aspects of the Tumor Microenvironment and Epithelial-Mesenchymal Transition in Gastric Carcinogenesis. Int J Mol Sci 2020;21:E2544. [PMID: 32268527 DOI: 10.3390/ijms21072544] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 7.0] [Reference Citation Analysis]
27 Zhou Q, Wu X, Wang X, Yu Z, Pan T, Li Z, Chang X, Jin Z, Li J, Zhu Z, Liu B, Su L. The reciprocal interaction between tumor cells and activated fibroblasts mediated by TNF-α/IL-33/ST2L signaling promotes gastric cancer metastasis. Oncogene 2020;39:1414-28. [PMID: 31659258 DOI: 10.1038/s41388-019-1078-x] [Cited by in Crossref: 20] [Cited by in F6Publishing: 24] [Article Influence: 6.7] [Reference Citation Analysis]
28 Wu X, Tao P, Zhou Q, Li J, Yu Z, Wang X, Li J, Li C, Yan M, Zhu Z. IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway. Oncotarget. 2017;8:20741-20750. [PMID: 28186964 DOI: 10.18632/oncotarget.15119] [Cited by in Crossref: 118] [Cited by in F6Publishing: 122] [Article Influence: 23.6] [Reference Citation Analysis]
29 Ishii G, Ishii T. Review of cancer-associated fibroblasts and their microenvironment in post-chemotherapy recurrence. Hum Cell 2020;33:938-45. [PMID: 32852669 DOI: 10.1007/s13577-020-00417-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Wang S, Ma N, Kawanishi S, Hiraku Y, Oikawa S, Xie Y, Zhang Z, Huang G, Murata M. Relationships of alpha-SMA-positive fibroblasts and SDF-1-positive tumor cells with neoangiogenesis in nasopharyngeal carcinoma. Biomed Res Int 2014;2014:507353. [PMID: 24877105 DOI: 10.1155/2014/507353] [Cited by in Crossref: 7] [Cited by in F6Publishing: 21] [Article Influence: 0.9] [Reference Citation Analysis]
31 Patel H, Nilendu P, Jahagirdar D, Pal JK, Sharma NK. Modulating secreted components of tumor microenvironment: A masterstroke in tumor therapeutics. Cancer Biol Ther 2018;19:3-12. [PMID: 29219656 DOI: 10.1080/15384047.2017.1394538] [Cited by in Crossref: 25] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
32 Chai XP, Sun GL, Fang YF, Hu LH, Liu X, Zhang XW. Tumor-targeting efficacy of a BF211 prodrug through hydrolysis by fibroblast activation protein-α. Acta Pharmacol Sin 2018;39:415-24. [PMID: 29119969 DOI: 10.1038/aps.2017.121] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
33 Hack SP, Bruey JM, Koeppen H. HGF/MET-directed therapeutics in gastroesophageal cancer: a review of clinical and biomarker development. Oncotarget 2014;5:2866-80. [PMID: 24930887 DOI: 10.18632/oncotarget.2003] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
34 Liu X, Xu Y, Zhou Q, Chen M, Zhang Y, Liang H, Zhao J, Zhong W, Wang M. PI3K in cancer: its structure, activation modes and role in shaping tumor microenvironment. Future Oncol. 2018;14:665-674. [PMID: 29219001 DOI: 10.2217/fon-2017-0588] [Cited by in Crossref: 25] [Cited by in F6Publishing: 26] [Article Influence: 5.0] [Reference Citation Analysis]
35 Yang TS, Yang XH, Chen X, Wang XD, Hua J, Zhou DL, Zhou B, Song ZS. MicroRNA-106b in cancer-associated fibroblasts from gastric cancer promotes cell migration and invasion by targeting PTEN. FEBS Lett. 2014;588:2162-2169. [PMID: 24842611 DOI: 10.1016/j.febslet.2014.04.050] [Cited by in Crossref: 66] [Cited by in F6Publishing: 66] [Article Influence: 8.3] [Reference Citation Analysis]
36 Oatmen KE, Cull E, Spinale FG. Heart failure as interstitial cancer: emergence of a malignant fibroblast phenotype. Nat Rev Cardiol 2020;17:523-31. [DOI: 10.1038/s41569-019-0286-y] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 4.0] [Reference Citation Analysis]
37 Hass R, Jennek S, Yang Y, Friedrich K. c-Met expression and activity in urogenital cancers - novel aspects of signal transduction and medical implications. Cell Commun Signal 2017;15:10. [PMID: 28212658 DOI: 10.1186/s12964-017-0165-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.8] [Reference Citation Analysis]
38 Wu Z, Chen R, Wu L, Zou L, Ding F, Wang M, Liu X. Bone marrow fibrosis at diagnosis predicts survival for primary acute myeloid leukemia. Clin Transl Oncol 2017;19:1462-8. [PMID: 28589431 DOI: 10.1007/s12094-017-1687-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
39 Mao X, Xu J, Wang W, Liang C, Hua J, Liu J, Zhang B, Meng Q, Yu X, Shi S. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives. Mol Cancer 2021;20:131. [PMID: 34635121 DOI: 10.1186/s12943-021-01428-1] [Reference Citation Analysis]
40 Yoshii S, Hayashi Y, Iijima H, Inoue T, Kimura K, Sakatani A, Nagai K, Fujinaga T, Hiyama S, Kodama T, Shinzaki S, Tsujii Y, Watabe K, Takehara T. Exosomal microRNAs derived from colon cancer cells promote tumor progression by suppressing fibroblast TP53 expression. Cancer Sci 2019;110:2396-407. [PMID: 31148360 DOI: 10.1111/cas.14084] [Cited by in Crossref: 27] [Cited by in F6Publishing: 33] [Article Influence: 9.0] [Reference Citation Analysis]
41 Gieniec KA, Butler LM, Worthley DL, Woods SL. Cancer-associated fibroblasts-heroes or villains? Br J Cancer 2019;121:293-302. [PMID: 31289350 DOI: 10.1038/s41416-019-0509-3] [Cited by in Crossref: 61] [Cited by in F6Publishing: 66] [Article Influence: 20.3] [Reference Citation Analysis]
42 Wang FT, Sun W, Zhang JT, Fan YZ. Cancer-associated fibroblast regulation of tumor neo-angiogenesis as a therapeutic target in cancer. Oncol Lett 2019;17:3055-65. [PMID: 30867734 DOI: 10.3892/ol.2019.9973] [Cited by in Crossref: 17] [Cited by in F6Publishing: 30] [Article Influence: 5.7] [Reference Citation Analysis]
43 Sakamoto N, Tsujimoto H, Takahata R, Cao B, Zhao P, Ito N, Shimazaki H, Ichikura T, Hase K, Vande Woude GF, Shinomiya N. MET4 expression predicts poor prognosis of gastric cancers with Helicobacter pylori infection. Cancer Sci 2017;108:322-30. [PMID: 28012218 DOI: 10.1111/cas.13146] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
44 Vigna E, Comoglio PM. Targeting the oncogenic Met receptor by antibodies and gene therapy. Oncogene 2015;34:1883-9. [PMID: 24882574 DOI: 10.1038/onc.2014.142] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
45 Otterpohl KL, Gould KA. Genetic dissection of the Mom5 modifier locus and evaluation of Mom5 candidate genes. Mamm Genome 2015;26:235-47. [PMID: 25976411 DOI: 10.1007/s00335-015-9567-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
46 Sun F, Feng M, Guan W. Mechanisms of peritoneal dissemination in gastric cancer. Oncol Lett 2017;14:6991-8. [PMID: 29344127 DOI: 10.3892/ol.2017.7149] [Cited by in Crossref: 8] [Cited by in F6Publishing: 19] [Article Influence: 1.6] [Reference Citation Analysis]
47 Wang X, Zhou Q, Yu Z, Wu X, Chen X, Li J, Li C, Yan M, Zhu Z, Liu B, Su L. Cancer-associated fibroblast-derived Lumican promotes gastric cancer progression via the integrin β1-FAK signaling pathway: Tumor-promoting effects of stromal Lumican in gastric cancer. Int J Cancer 2017;141:998-1010. [DOI: 10.1002/ijc.30801] [Cited by in Crossref: 42] [Cited by in F6Publishing: 43] [Article Influence: 8.4] [Reference Citation Analysis]
48 Kawakami H, Okamoto I. MET-targeted therapy for gastric cancer: the importance of a biomarker-based strategy. Gastric Cancer. 2016;19:687-695. [PMID: 26690587 DOI: 10.1007/s10120-015-0585-x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
49 Liu T, Zhou L, Li D, Andl T, Zhang Y. Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment. Front Cell Dev Biol 2019;7:60. [PMID: 31106200 DOI: 10.3389/fcell.2019.00060] [Cited by in Crossref: 131] [Cited by in F6Publishing: 130] [Article Influence: 43.7] [Reference Citation Analysis]
50 Suzuki E, Yamazaki S, Naito T, Hashimoto H, Okubo S, Udagawa H, Goto K, Tsuboi M, Ochiai A, Ishii G. Secretion of high amounts of hepatocyte growth factor is a characteristic feature of cancer‐associated fibroblasts with EGFR‐TKI resistance‐promoting phenotype: A study of 18 cases of cancer‐associated fibroblasts. Pathol Int 2019;69:472-80. [DOI: 10.1111/pin.12838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.7] [Reference Citation Analysis]
51 Esfandi F, Salehnezhad T, Taheri M, Afsharpad M, Hafez AA, Oskooei VK, Ghafouri-Fard S. Expression assessment of a panel of long non-coding RNAs in gastric malignancy. Exp Mol Pathol 2020;113:104383. [PMID: 31982396 DOI: 10.1016/j.yexmp.2020.104383] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
52 Bai YP, Shang K, Chen H, Ding F, Wang Z, Liang C, Xu Y, Sun MH, Li YY. FGF-1/-3/FGFR4 signaling in cancer-associated fibroblasts promotes tumor progression in colon cancer through Erk and MMP-7. Cancer Sci 2015;106:1278-87. [PMID: 26183471 DOI: 10.1111/cas.12745] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 6.7] [Reference Citation Analysis]
53 Ding X, Ji J, Jiang J, Cai Q, Wang C, Shi M, Yu Y, Zhu Z, Zhang J. HGF-mediated crosstalk between cancer-associated fibroblasts and MET-unamplified gastric cancer cells activates coordinated tumorigenesis and metastasis. Cell Death Dis 2018;9:867. [PMID: 30158543 DOI: 10.1038/s41419-018-0922-1] [Cited by in Crossref: 25] [Cited by in F6Publishing: 30] [Article Influence: 6.3] [Reference Citation Analysis]